ASTRO President’s Corner: Mark Cuban

ASTRO President Dr. Neha Vapiwala speaks with Dr. Alison Tree, MD (Res), a Doctor of Medicine by Research and consultant clinical oncologist at The Royal Marsden specializing in radiotherapy and chemotherapy treatment for urological malignancies. Dr Tree leads the Prostate Group in the International MR Linac consortium, which she now also chairs. She is lead GU editor for ASTRO’s International Journal of Radiation Oncology Biology and Physics (Red Journal).

ASTRO President Neha Vapiwala and CEO Vivek Kavadi talk with Karen Knudsen, CEO of the Parker Institute for Cancer Immunotherapy, and former CEO of the American Cancer Society, ahead of the 2026 Annual Meeting in Boston. They preview the Presidential Symposium's data to dialogue theme, diving into research collaboration, combining radiation therapy and immunotherapy, and communicating cancer science to patients, families and the public. Plus a sneak peek of the Presidential Symposium in Boston.

ASTRO President Dr. Neha Vapiwala speaks with Dr. Matthew Manning, a community radiation oncologist with Piedmont Radiation Oncology and Cone Health in Greensboro, North Carolina. Dr. Manning serves on the ASTRO Nominating Committee and is a founding member of ASTRO's Community Practice Task Force.

ASTRO President Dr. Neha Vapiwala speaks with Shark Tank’s Mark Cuban, founder of Mark Cuban Cost Plus Drug Company. In this episode, they discuss the state of the healthcare sector including projections of physician shortages, the role insurance authorizations play our in daily practice, the impact that AI has on medial practices today, how it impacts patient’s understanding of their health condition, including misinformation, and Mark’s projections on how AI will play out in the healthcare space in the years to come

In the latest episode of our series on AI in Radiation Oncology, Liam Ghiam, MD, a member of ASTRO's AI Subcommittee, sits down with radiation oncology residents Nikhil Kotha, (Stanford), Alex Chen (UCSF), and Mitchell Parker (MSKCC) to discuss how AI is impacting radiation oncology residency training. Together, they explore the evolving role of AI and its specific impacts on training and workflows.

ASTRO President Dr. Neha Vapiwala speaks with Dr. Nadine Housri, Adjunct Associate Professor at Yale University and co-founder & Chief Medical Officer of MedNet. Dr. Housri shares how MedNet originated and how the platform facilitates knowledge sharing among oncologists through online discussions and clinical insights. She also talks about the future of MedNet and patient communication in an AI-driven era.

In this episode, continuing our series on AI in Radiation Oncology, Eva Katsoulakis, MD, a member of ASTRO's AI Resource Panel, speaks with Kurt Sysock, CEO and co-founder of Radformation, about how AI is transforming the clinical workflow in radiation oncology from autosegmentation and adaptive therapy to treatment planning, quality assurance, and the road ahead. 

ASTRO President Dr. Neha Vapiwala talks with Australian ASTRO member Dr. Sandra Turner co-chair of World Radiotherapy Awareness Day. Dr. Turner discusses the evolution of Australia's Targeting Cancer campaign and the establishment of World Radiotherapy Awareness Day, celebrated each year on September 7th, of which ASTRO is both a supporter and part of the planning committee.

In this episode, members of ASTRO's AI Resource Panel explore how artificial intelligence is transforming radiation oncology. The discussion covers the rationale for the development of ASTRO's AI consensus guidance, safety considerations, and what responsible AI adoption means for clinicians and patients as these tools move into routine practice. 

ASTRO President Dr. Neha Vapiwala and Board Chair Dr. Sameer Keole discuss expanding indications for radiation therapy including functional radiation medicine along with emerging opportunities in radiopharmaceutical therapy.